Press Releases Any 2022 2021 (-) 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2020 November 23, 2020 argenx Enters Into Agreement To Acquire Priority Review Voucher November 17, 2020 argenx Premieres A Mystery to Me, a Docuseries Inspired by the Myasthenia Gravis Patient Experience November 9, 2020 argenx to Participate in Upcoming Virtual Investor Conferences October 22, 2020 argenx Reports Third Quarter 2020 Financial Results and Provides Business Update October 15, 2020 argenx to Report Third Quarter 2020 Financial Results and Business Update on October 22, 2020 October 6, 2020 argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships October 5, 2020 argenx Presents Additional Efgartigimod Data from Global Phase 3 ADAPT Trial at the Myasthenia Gravis Foundation of America 2020 Scientific Session September 18, 2020 argenx to Present Additional Data from Global Phase 3 ADAPT Trial of Efgartigimod for Myasthenia Gravis at Upcoming Virtual Medical Meetings September 2, 2020 argenx Management to Present at Upcoming Virtual Investor Conferences August 4, 2020 argenx to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference July 30, 2020 argenx reports half year 2020 financial results and provides second quarter business update July 23, 2020 argenx to report half year 2020 financial results and second quarter business update on July 30, 2020 Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
